Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Aliskiren and Furosemide in Heart Failure
NCT01125514Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, single-blind, single-arm trial of aliskiren in heart failure (HF), sponsored by Novartis. Primary endpoints: Diuretic Efficacy Index 1 for Sodium Excretion and Diuretic Efficacy Index 2 for Water Excretion. Started May 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01125514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125514.